• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10619
Device Problem Defective Device (2588)
Patient Problem Vascular Dissection (3160)
Event Date 06/28/2022
Event Type  Injury  
Event Description
It was reported that a dissection occurred.The patient presented with chest pain for percutaneous transluminal coronary angioplasty.The target lesion was located in the moderately tortuous and moderately calcified left anterior descending artery.A 2.50 x 20 synergy stent was implanted but after it was deployed it was noted that the stent failed to cover the full lesion proximally and there was a non-flow limiting mild dissection proximal to the stent.A 2.75 x 32 synergy stent was implanted overlapping the first stent, and covering the missed lesion and dissection.The patient was doing well.
 
Manufacturer Narrative
Initial reporter address 1: (b)(4).
 
Manufacturer Narrative
E1: initial reporter address 1: (b)(6).
 
Event Description
It was reported that a dissection occurred.The patient presented with chest pain for percutaneous transluminal coronary angioplasty.The target lesion was located in the moderately tortuous and moderately calcified left anterior descending artery.A 2.50 x 20 synergy stent was implanted but after it was deployed it was noted that the stent failed to cover the full lesion proximally and there was a non-flow limiting mild dissection proximal to the stent.A 2.75 x 32 synergy stent was implanted overlapping the first stent, and covering the missed lesion and dissection.The patient was doing well.It was further reported that the stent was found to be shorter than the lesion.It was noted that the initially assessed that the 2.50 x 20 synergy stent would cover the 18-20mm lesion, but after deployment, the stent was noted to be a little shorter than the lesion and mild proximal stent dissection was observed.A 2.75 x 32 synergy stent was deployed to cover the rest of the missed lesion and dissection, proximally.Intravascular ultrasound (ivus) was not performed.No further patient complications were reported in relation to this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key15047676
MDR Text Key296124243
Report Number2124215-2022-26190
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeIN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/18/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/11/2024
Device Model Number10619
Device Catalogue Number10619
Device Lot Number0028741670
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/04/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/11/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient RaceAsian
-
-